CoChat

Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease

Open access

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.

Abstract

Disease-Associated Microglia (DAM) are a focus in Alzheimer’s disease (AD) research due to their central involvement in the response to amyloid-beta plaques. Microglial Toll-like receptor 4 (TLR4) is instrumental in the binding of fibrillary amyloid proteins, while Lyn kinase (Lyn) is a member of the Src family of non-receptor tyrosine kinases involved in immune signaling. Lyn is a novel, non-canonical, intracellular adaptor with diverse roles in cell-specific signaling which directly binds to TLR4 to modify its function. Lyn can be activated in response to TLR4 stimulation, leading to phosphorylation of various substrates and modulation of inflammatory and phagocytosis signaling pathways. Here, we investigated the TLR4-Lyn interaction in neuroinflammation using WT, 5XFAD, and 5XFAD x Lyn -/- mouse models by western blotting (WB), co-immunoprecipitation (co-IP), immunohistochemistry (IHC) and flow cytometric (FC) analysis. A spatial transcriptomic analysis of microglia in WT, 5XFAD, and 5XFAD x Lyn -/- mice revealed essential genes involved in neuroinflammation, Aβ phagocytosis, and neuronal damage. Finally, we explored the effects of a synthetic, TLR4-Lyn modulator protein (TLIM) through an in vitro AD model using primary murine microglia. Our WB, co-IP, IHC, and FC data show an increased, novel, direct protein–protein interaction between TLR4 and Lyn kinase in the brains of 5XFAD mice compared to WT. Furthermore, in the absence of Lyn (5XFAD x Lyn -/- mice); increased expression of protective Syk kinase was observed, enhanced microglial Aβ phagocytosis, increased astrocyte activity, decreased neuronal dystrophy, and a further increase in the cell survival signaling and protective DAM population was noted. The DAM population in 5XFAD mice which produce more inflammatory cytokines and phagocytose more Aβ were observed to express greater levels of TLR4 and Lyn. Pathway analysis comparison between WT, 5XFAD, and 5XFAD x Lyn -/- mice supported these findings via our microglial spatial transcriptomic analysis. Finally, we created an in vitro co-culture system with primary murine microglial and primary murine hippocampal cells exposed to Aβ as a model of AD. When these co-cultures were treated with our TLR4-Lyn Interaction Modulators (TLIMs), an increase in Aβ phagocytosis and a decrease in neuronal dystrophy was seen. Lyn kinase has a central role in modulating TLR4-induced inflammation and Syk-induced protection in a 5XFAD mouse model. Our TLIMs ameliorate AD sequalae in an in vitro model of AD and could be a promising therapeutic strategy to treat AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-025-96456-y

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Macrophage TLR4-Lyn co-expressions in Alzheimer’s mouse brain. a) IHC imaging of WT and 5xFAD mouse brains for Lyn (1:350; green) and TLR4 (1:500; red). All scale bars = 50 µm. b) Surface plots of Lyn-TLR4 colocalization for each group was quantified using ImageJ software, yellow color represents highest possible colocalization. c) Co-immunoprecipitation of Lyn kinase and TLR4 to establish direct interaction between the two proteins in AD vs WT mice brains. d) DAMs are characterized by CD11c+Clec7a+ population plotted on microglia (CD11b+CD45med) in mouse brains. Bottom plots show Lyn and TLR4 double positive DAMs. e) Quantification of DAMs and the DAM subset that is pLyn and TLR4 double positive. (n = 4; students t-test *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).
Fig. 1 Macrophage TLR4-Lyn co-expressions in Alzheimer’s mouse brain. a) IHC imaging of WT and 5xFAD mouse brains for Lyn (1:350; green) and TLR4 (1:500; red). All scale bars = 50 µm. b) Surface plots of Lyn-TLR4 colocalization for each group was quantified using ImageJ software, yellow color represents highest possible colocalization. c) Co-immunoprecipitation of Lyn kinase and TLR4 to establish direct interaction between the two proteins in AD vs WT mice brains. d) DAMs are characterized by CD11c+Clec7a+ population plotted on microglia (CD11b+CD45med) in mouse brains. Bottom plots show Lyn and TLR4 double positive DAMs. e) Quantification of DAMs and the DAM subset that is pLyn and TLR4 double positive. (n = 4; students t-test *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).CC BY-NC-ND · PubMed Central
Fig. 2 Cell signaling pathway analysis. a) WB of TLR4, pLyn, Lyn, pSyk, Syk, PI3K, pAkt, Akt, pGSK3β, and GSK3β in WT, 5xFAD and 5xFAD X Lyn-/-mice, GAPDH was used as loading control. b) Quantification of band area of the proteins analyzed by western blot, n = 3; F = 70.34, 99.16, 74.45, 93.51, 76.57, 90.32, 71.08, 52.35, 51.50, 57.97 for all proteins, respectively. F for GAPDH was 1.03 and not significant. One-Way ANOVA, *P < 0.05, **P < 0.001, ***P < 0.0001 between groups. c) Immunohistochemical imaging of 5xFAD and 5xFAD X Lyn-/-mice for Lyn (1:350; green) and TLR4 (1:500; red). All scale bars = 50 µm. Surface plots of Lyn-TLR4 colocalization for each group was quantified using ImageJ software, yellow color represents highest possible colocalization. d) Flow cytometric analysis of Syk, TLR4, Lyn expression on the total brain cells of WT, 5XFAD and 5XFAD X Lyn-/- mice. e) Quantification of Syk (F = 75.29), TLR4 (F = 43.56), Lyn (F = 48.15) expression by the brain cells (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).
Fig. 2 Cell signaling pathway analysis. a) WB of TLR4, pLyn, Lyn, pSyk, Syk, PI3K, pAkt, Akt, pGSK3β, and GSK3β in WT, 5xFAD and 5xFAD X Lyn-/-mice, GAPDH was used as loading control. b) Quantification of band area of the proteins analyzed by western blot, n = 3; F = 70.34, 99.16, 74.45, 93.51, 76.57, 90.32, 71.08, 52.35, 51.50, 57.97 for all proteins, respectively. F for GAPDH was 1.03 and not significant. One-Way ANOVA, *P < 0.05, **P < 0.001, ***P < 0.0001 between groups. c) Immunohistochemical imaging of 5xFAD and 5xFAD X Lyn-/-mice for Lyn (1:350; green) and TLR4 (1:500; red). All scale bars = 50 µm. Surface plots of Lyn-TLR4 colocalization for each group was quantified using ImageJ software, yellow color represents highest possible colocalization. d) Flow cytometric analysis of Syk, TLR4, Lyn expression on the total brain cells of WT, 5XFAD and 5XFAD X Lyn-/- mice. e) Quantification of Syk (F = 75.29), TLR4 (F = 43.56), Lyn (F = 48.15) expression by the brain cells (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).CC BY-NC-ND · PubMed Central
Fig. 3 Microglial morphology analysis and inflammatory cytokine (IFNɣ) production. a) The ratio of cell body area to pseudopodia area was calculated and termed microglial morphology analysis index (MMAI), scale bars = 10 µm. Area measurements were done using ImageJ software. n = 4 ; F = 39.82, statistical analysis was done by one-way ANOVA, *P < 0.05, **P < 0.001, ***P < 0.0001 between groups. b) IHC imaging of 5xFAD and 5xFAD X Lyn-/-mice for GFAP (1:500; red), counterstained with DAPI (blue), scale bars = 50 µm. c) Quantification of reactive astrocytes (GFAP+) per field (n = 4; Student’s t-test *P < 0.05 between groups). Flow analysis of TNF⍺ and IFNɣ production by microglia, characterized by CD11b+CD45med populations of WT, 5XFAD and 5XFAD X Lyn-/- mouse brains. e) Quantification of TNF⍺ (F = 25.48) and IFNɣ (F = 114) production by the MG (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).
Fig. 3 Microglial morphology analysis and inflammatory cytokine (IFNɣ) production. a) The ratio of cell body area to pseudopodia area was calculated and termed microglial morphology analysis index (MMAI), scale bars = 10 µm. Area measurements were done using ImageJ software. n = 4 ; F = 39.82, statistical analysis was done by one-way ANOVA, *P < 0.05, **P < 0.001, ***P < 0.0001 between groups. b) IHC imaging of 5xFAD and 5xFAD X Lyn-/-mice for GFAP (1:500; red), counterstained with DAPI (blue), scale bars = 50 µm. c) Quantification of reactive astrocytes (GFAP+) per field (n = 4; Student’s t-test *P < 0.05 between groups). Flow analysis of TNF⍺ and IFNɣ production by microglia, characterized by CD11b+CD45med populations of WT, 5XFAD and 5XFAD X Lyn-/- mouse brains. e) Quantification of TNF⍺ (F = 25.48) and IFNɣ (F = 114) production by the MG (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).CC BY-NC-ND · PubMed Central
Fig. 4 Spatial transcriptomics analysis of microglia specific genes and functional pathways. Heatmaps generated by gene set enrichment analysis (GSEA) of set of signature genes expression in the microglia of WT, 5XFAD and 5XFAD X Lyn-/- mice involved in a) inflammatory cytokine signaling pathway and b) microglial phagocytosis pathways c) cell signaling pathway d) primary component analysis (PCA) plot on the genes involved in phagocytosis in 5XFAD and 5XFAD X Lyn-/- e) volcano plot compares the microglial gene upregulation in 5XFAD and 5XFAD X Lyn-/- mouse.
Fig. 4 Spatial transcriptomics analysis of microglia specific genes and functional pathways. Heatmaps generated by gene set enrichment analysis (GSEA) of set of signature genes expression in the microglia of WT, 5XFAD and 5XFAD X Lyn-/- mice involved in a) inflammatory cytokine signaling pathway and b) microglial phagocytosis pathways c) cell signaling pathway d) primary component analysis (PCA) plot on the genes involved in phagocytosis in 5XFAD and 5XFAD X Lyn-/- e) volcano plot compares the microglial gene upregulation in 5XFAD and 5XFAD X Lyn-/- mouse.CC BY-NC-ND · PubMed Central
Fig. 5 In vivo phagocytosis of Aβ in WT, 5xFAD and 5xFAD X Lyn-/- mouse brain cells. a) Immunostaining of Iba-1 (green), Aβ oligomers were bound to the IP administered methoxy-X04 (Me-X04) (red), all scale bars = 50 µm b) Surface plots for Iba1-Me-X04 colocalization. c) in vivo Aβ phagocytosis measured by Tmem119+Me-X04+ population gated on DAMs (CD11c+Clec7a+), plotted on microglia (CD11b+CD45med). Data analyzed by FlowJo; d) Quantification of DAMs (F = 37.70) and DAM Aβ phagocytosis (F = 31.32). (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).
Fig. 5 In vivo phagocytosis of Aβ in WT, 5xFAD and 5xFAD X Lyn-/- mouse brain cells. a) Immunostaining of Iba-1 (green), Aβ oligomers were bound to the IP administered methoxy-X04 (Me-X04) (red), all scale bars = 50 µm b) Surface plots for Iba1-Me-X04 colocalization. c) in vivo Aβ phagocytosis measured by Tmem119+Me-X04+ population gated on DAMs (CD11c+Clec7a+), plotted on microglia (CD11b+CD45med). Data analyzed by FlowJo; d) Quantification of DAMs (F = 37.70) and DAM Aβ phagocytosis (F = 31.32). (n = 4; One-way ANOVA *P < 0.05, **P < 0.001, ***P < 0.0001 between groups).CC BY-NC-ND · PubMed Central
Fig. 6 Lyn controls neuronal dystrophy and cognitive dysfunction in AD. a) Immunostaining to determine dystrophic neurites around the Aβ plaque. WT, 5xFAD and 5xFAD X Lyn-/- mouse brain cortical sections were stained with AT8 (green) for phosphorylated tau (p-tau) and Aβ (red). All scale bars = 50 µm. b) Surface plots for AT8-Aβ colocalization. c) Cognitive function test by Barnes maze (F = 54.80, 2-way ANOVA where the 2 variables are time and genotype to assess for differences amongst all groups and Bonferroni post hoc test to assess for differences between pairs of groups). d) Discrimination index measured by Novel object recognition test (F = 37.23, One way ANOVA). n = 6; *P < 0.05, **P < 0.001, ***P < 0.0001 were considered statistically significant. e) Flow analysis to determine the neuronal population in the brain cells using anti-mouse NeuN, a neuronal marker. f) Quantification of neuronal cell percentage in the mouse brain by measuring Neun+ cells, n = 3; F = 52.10, One-way ANOVA to assess for differences amongst all groups and Bonferroni post hoc test to assess for differences between pairs of groups. *P < 0.05, **P < 0.001, ***P < 0.0001 was considered statistically significant.
Fig. 6 Lyn controls neuronal dystrophy and cognitive dysfunction in AD. a) Immunostaining to determine dystrophic neurites around the Aβ plaque. WT, 5xFAD and 5xFAD X Lyn-/- mouse brain cortical sections were stained with AT8 (green) for phosphorylated tau (p-tau) and Aβ (red). All scale bars = 50 µm. b) Surface plots for AT8-Aβ colocalization. c) Cognitive function test by Barnes maze (F = 54.80, 2-way ANOVA where the 2 variables are time and genotype to assess for differences amongst all groups and Bonferroni post hoc test to assess for differences between pairs of groups). d) Discrimination index measured by Novel object recognition test (F = 37.23, One way ANOVA). n = 6; *P < 0.05, **P < 0.001, ***P < 0.0001 were considered statistically significant. e) Flow analysis to determine the neuronal population in the brain cells using anti-mouse NeuN, a neuronal marker. f) Quantification of neuronal cell percentage in the mouse brain by measuring Neun+ cells, n = 3; F = 52.10, One-way ANOVA to assess for differences amongst all groups and Bonferroni post hoc test to assess for differences between pairs of groups. *P < 0.05, **P < 0.001, ***P < 0.0001 was considered statistically significant.CC BY-NC-ND · PubMed Central
Fig. 7 Effects of TLIM on TLR4-Lyn interaction to improve microglial phagocytosis and neuronal dystrophy. a) TLR4 domains, region of interaction (ROI) defining TLR4-TLIM and Dose–response curve for TLR4-TLIM IC50 = 17.9 nM. b) Microglial phagocytosis assay; primary microglia were incubated with pHrodo tagged Aβ1-42 oligomers and GST-liposomes or TLIM-liposomes. Data analyzed by FlowJo; n = 4 per group. Quantifications of c) DAMs, d) Lyn+TLR4+ positive DAMs and e) DAM-Aβ phagocytosis in GST or TLIM liposome treated AD-microglia cultures (n = 4; Student’s t-test *P < 0.05, **P < 0.001 between groups). f) Microglia-Neuron Trans-well Assay. Primary microglia (MG) plated on the top chamber and neuronal cell line (hippocampal) plated in the bottom chamber. Cells were incubated with Aβ oligomers for 2 h, followed by 1-h incubation with 20 nM of either GST-liposomes or TLIM-liposomes. g) Immunohistochemistry staining of AT8 (green, 1:500) and DAPI (blue) in Aβ treated trans-well cultures. h) Quantification of number of dystrophic neurites per filed stained with AT8 (green), scale bars = 25 µm n = 4; Student’s t-test *P < 0.05, **P < 0.001 between groups.
Fig. 7 Effects of TLIM on TLR4-Lyn interaction to improve microglial phagocytosis and neuronal dystrophy. a) TLR4 domains, region of interaction (ROI) defining TLR4-TLIM and Dose–response curve for TLR4-TLIM IC50 = 17.9 nM. b) Microglial phagocytosis assay; primary microglia were incubated with pHrodo tagged Aβ1-42 oligomers and GST-liposomes or TLIM-liposomes. Data analyzed by FlowJo; n = 4 per group. Quantifications of c) DAMs, d) Lyn+TLR4+ positive DAMs and e) DAM-Aβ phagocytosis in GST or TLIM liposome treated AD-microglia cultures (n = 4; Student’s t-test *P < 0.05, **P < 0.001 between groups). f) Microglia-Neuron Trans-well Assay. Primary microglia (MG) plated on the top chamber and neuronal cell line (hippocampal) plated in the bottom chamber. Cells were incubated with Aβ oligomers for 2 h, followed by 1-h incubation with 20 nM of either GST-liposomes or TLIM-liposomes. g) Immunohistochemistry staining of AT8 (green, 1:500) and DAPI (blue) in Aβ treated trans-well cultures. h) Quantification of number of dystrophic neurites per filed stained with AT8 (green), scale bars = 25 µm n = 4; Student’s t-test *P < 0.05, **P < 0.001 between groups.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Cited by

See all 22

Metadata

Authors
Islam, R., Choudhary, H. H., Zhang, F., Mehta, H., Yoshida, J., Thomas, A. J., & Hanafy, K.
Affiliations
Cooper Medical School of Rowan University (US)
Corresponding author
Hanafy, Khalid
Venue
Scientific Reports
Published
2025-04-03
Volume
15
Issue
1
Pages
11368-11368
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4409148053
Cited by
22
References
60
Citations by year
2026: 15 · 2025: 7
FWCI
7.94
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Neurological Disorders and Stroke (R01NS109174)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
Alzheimer's disease, disease-associated microglia, TLR4, Lyn kinase, neuroinflammation, amyloid-beta phagocytosis, neuronal injury, cell survival signaling, Syk, astrocyte activation, 5xFAD mice
MeSH terms
Neuroinflammatory Diseases, Alzheimer Disease, Animals, Cell Survival, Disease Models, Animal, Humans, Mice, Transgenic, Neurons, Phagocytosis, Signal Transduction, Amyloid beta-Peptides, Microglia, Mice, Knockout, src-Family Kinases, Toll-Like Receptor 4, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41598-025-96456-y
The paper
Islam, R., Choudhary, H. H., Zhang, F., Mehta, H., Yoshida, J., Thomas, A. J., & Hanafy, K. (2025). Microglial TLR4-Lyn kinase is a critical regulator of neuroinflammation, Aβ phagocytosis, neuronal damage, and cell survival in Alzheimer’s disease. Scientific Reports. https://doi.org/10.1038/s41598-025-96456-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.